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Previous studies have documented adverse effects of alcohol on oculomotor 
performance. For example, moderate-dose alcohol (yielding a Blood Alcohol 
Concentration or BAC of 0.04-0.1%) has been shown to decrease steady-state 
pursuit gain (Fransson et al., 2010, Clin Neurophysiol, 121(12): 2134; Moser et al., 
1998, J Neurol, 245(8): 542; Roche & King, 2010, Psychopharmacology, 212(1): 
33), to increase saccade latency (Moser et al., 1998, J Neurol, 245(8): 542; Roche 
& King, 2010, Psychopharmacology, 212(1): 33), to decrease peak saccadic 
velocity (Fransson et al., 2010, Clin Neurophysiol, 121(12): 2134; Roche & King, 
2010, Psychopharmacology, 212(1): 33), and to increase the frequency of catch-up 
saccades (Moser et al., 1998, J Neurol, 245(8): 542). Here, we administered two 
doses of ethanol on different days, yielding moderate (0.06%) and low (0.02%) 
levels of initial BAC, to examine the effects on human ocular tracking over BACs 
ranging from 0.00 to 0.07%. Twelve subjects (8 females) participated in a 5-day 
study. Three days of at-home measurements of daily activity and sleep were 
monitored, followed by two laboratory days where, ~5 hours after awakening, we 
administered one of the two possible single doses of alcohol. Using a previously 
published paradigm (Liston & Stone, 2014, J Vis, 14(14): 12), we measured 
oculomotor performance multiple times throughout the day with three pre-dosing 
baseline runs and bi-hourly post-dosing test runs until the subject recorded a BAC 
of 0.00% for two hours. BAC was measured before each run using an Alco-Sensor 
IV breathalyzer (Intoximeters, Inc., St. Louis, MO). For each of the oculometric 
measures, for each subject, we computed the within-subject % deviation for each 
test run from their baseline averaged across their three pre-dosing runs. We then 
averaged the data across subjects in 0.01% BAC bins. Finally, we used linear 
regression to compute the slope and x-intercept (threshold) of the mean binned % 
deviation as a function of BAC. We found that pursuit initiation was impaired at 
very low BAC levels, with significant (p < 0.002) linear trends in latency 
(+1.3%/0.01%BAC) and initial acceleration (-4.6%/0.01%BAC) with extrapolated 
absolute thresholds at or below 0.01% BAC. We also found that steady-state 
tracking was impaired showing significant (p < 0.002) linear trends in gain (-
3.8%/0.01%BAC) and catch-up saccade amplitude (+9.1%/0.01%BAC), again 
with extrapolated absolute thresholds around 0.01% BAC. We also found a 
significant (p < 0.02) increase in pursuit direction noise (+9.8%/0.01%BAC) with 
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an extrapolated absolute threshold below 0.01% BAC. Many aspects of ocular 
tracking are impaired in a dose-dependent manner beginning at a BAC level 
around 0.01%, with significant effects at levels lower than previously reported and 









































































•  Speed	precision	is	unchanged	(p	=	0.48)	with	BAC	 •  Centripetal	driq	increases	signiﬁcantly	(p	<	0.01)	with	BAC	
•  Slope	=	-0.008	deg/s/0.01%	BAC	and	threshold	=	-0.002%	BAC		
•  Lateral	driq	is	unchanged	(p	=	0.8)	with	BAC.	
